Drug Shortage Report for ADENOSINE INJECTION
| Report ID | 173478 |
| Drug Identification Number | 02267659 |
| Brand name | ADENOSINE INJECTION |
| Common or Proper name | ADENOSINE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ADENOSINE |
| Strength(s) | 3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2 mL |
| ATC code | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-11-01 |
| Actual start date | 2022-11-01 |
| Estimated end date | 2023-01-31 |
| Actual end date | 2022-12-31 |
| Shortage status | Resolved |
| Updated date | 2023-01-02 |
| Company comments | Product is on 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-01-02 | French | Compare |
| v3 | 2023-01-02 | English | Compare |
| v2 | 2022-11-03 | French | Compare |
| v1 | 2022-11-03 | English | Compare |
Showing 1 to 4 of 4